<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04885686</url>
  </required_header>
  <id_info>
    <org_study_id>EndoPOP</org_study_id>
    <secondary_id>2021-A00065-36</secondary_id>
    <nct_id>NCT04885686</nct_id>
  </id_info>
  <brief_title>Endodontic Post-operative Pain Evaluation of Patients After Using Endomethasone N or Endomethasone SP (EndoPOP)</brief_title>
  <acronym>EndoPOP</acronym>
  <official_title>Endodontic Post-operative Pain Evaluation of Patients After Using Endomethasone N or Endomethasone SP Root Canal Sealer: a Prospective, Comparative Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Septodont</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Slb Pharma</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Septodont</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a post-marketing performance and safety study, designed as a comparative,&#xD;
      prospective, multicenter, simple-blind, randomized clinical trial. 300 subjects requiring a&#xD;
      primary or a secondary root canal treatment will be enrolled in 2 groups (150 in each group).&#xD;
      The aim of the study is to demonstrate the superiority of the hydrocortisone-containing root&#xD;
      canal sealer Endomethasone N RCS, compared to the hydrocortisone-free root canal sealer&#xD;
      Endomethasone SP RCS, with regard to reduction of the maximum post-operative spontaneous pain&#xD;
      during the 7 days following the root canal treatment.&#xD;
&#xD;
      Root canal treatment procedures will be in accordance with the allocation by randomisation of&#xD;
      Endomethasone N RCS or Endomethasone SP RCS. The spontaneous and the Masticatory pain will be&#xD;
      record at predefined times, a phone call will be done at 48h and a visit will be realized at&#xD;
      day 7 (max Day 14).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 22, 2021</start_date>
  <completion_date type="Anticipated">February 28, 2022</completion_date>
  <primary_completion_date type="Actual">July 6, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Study subject will be randomized in a 1:1 allocation ratio between the 2 treatment groups; the allocation will be stratified by pre-operative pain (3 classes) and center (12 classes).</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>The color of the two powders are not the same. The dentist will not be blinded to the treatment, but the patient will. The study is simple-blinded.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Maximum post-operative pain using a visual analogue scale (VAS : 0-100)</measure>
    <time_frame>from the end of the root canal treatment (Day 0) to Day 7</time_frame>
    <description>The pain is assessed by patients in a diary using a Visual Analogue Scale (VAS: 0-100 mm; 0 no pain - 100 maximum pain) at different times after endodontic treatment (at the end of the root canal obturation, 3h, 6h 12h, 24h, Day 2, Day 3, Day 4 Day 5, Day 5, Day 7). The maximum pain felt will be compared between the 2 groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Spontaneous pain intensity</measure>
    <time_frame>from the end of the root canal treatment (Day 0) to Day 7</time_frame>
    <description>The spontaneous pain intensity measured using a Visual Analogue Scale (VAS: 0-100mm; 0 no pain - 100 maximum pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of spontaneous pain flare-ups</measure>
    <time_frame>From Day 3 to Day7</time_frame>
    <description>The occurrence of spontaneous pain flare-ups is an increase of 20 mm in the Visual Analogue Scale (VAS: 0-100mm; 0 no pain-100 maximum pain) between 2 consecutive measurements after the firsts 3 days.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Masticatory pain intensity</measure>
    <time_frame>from the end of the root canal treatment (Day 0) to Day 7</time_frame>
    <description>The masticatory pain intensity measured using a Visual Analogue Scale (VAS: 0-100mm; 0 no pain -100 maximum pain) assessed twice a day from Day 0 to Day3 (lunch and dinner), and once a day from Day 4 to Day7 (dinner).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum Masticatory pain intensity using a visual analogue scale (VAS : 0-100mm)</measure>
    <time_frame>from the end of the root canal treatment (Day 0) to Day 7</time_frame>
    <description>The maximum masticatory pain intensity measured Visual Analogue Scale (VAS: 0-100mm; 0 no pain- 100 maximum pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of oral pain treatment</measure>
    <time_frame>from the end of the root canal treatment (Day 0) to Day 7</time_frame>
    <description>Patients reported the consumption of analgesic treatment in a diary. The proportion of patients who took oral pain medication and the treatment categories will be compared between the 2 groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life with the OHIP-17 questionnaire (score 0-68)</measure>
    <time_frame>baseline and from 48 to 72 hours</time_frame>
    <description>The answers and the total score from the OHIP 17-items questionnaire (measured at baseline and 48 h) will be compared between 2 groups. Score between 0 and 68, 0 means no dental issuel, 68 all the issues very often.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>from the inclusion (Day 0) to Day 7</time_frame>
    <description>Adverse events reported by patients on a diary from Day 0 to Day 7 and adverse events clinically observed by the dental surgeon at each follow-up visit will be used to assess the safety of root canal sealers and endodontic procedures</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Root Canal Obturation</condition>
  <arm_group>
    <arm_group_label>Endomethasone N RCS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Endomethasone N RCS is used in combination with gutta percha points for the permanent obturation of root canals.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Endomethasone SP RCS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Endomethasone SP RCS is used in combination with gutta percha points for the permanent obturation of root canals.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endomethasone N RCS</intervention_name>
    <description>Root canal sealer</description>
    <arm_group_label>Endomethasone N RCS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endomethasone SP RCS</intervention_name>
    <description>Root canal sealer</description>
    <arm_group_label>Endomethasone SP RCS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult male or female (age ≥ 18 years);&#xD;
&#xD;
          -  Patient requiring root canal treatment or retreatment;&#xD;
&#xD;
          -  Patient who will need a single visit for the root canal therapy, for a mature molar or&#xD;
             second premolar, with or without pre-operative pain&#xD;
&#xD;
          -  Patient who received information and gave written consent (signed informed consent&#xD;
             form);&#xD;
&#xD;
          -  Subject affiliated to a health insurance system, or is a beneficiary (art. L.1121-11,&#xD;
             Code of Public Health, France).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pulpotomy or pulpectomy performed at a prior visit;&#xD;
&#xD;
          -  Tooth with apical calcification (sealer unable to reach the root apex);&#xD;
&#xD;
          -  Tooth with suspected root perforation;&#xD;
&#xD;
          -  Immature tooth (too wide root apex requiring an apexification);&#xD;
&#xD;
          -  Other dental treatment ongoing or scheduled within the study period;&#xD;
&#xD;
          -  At least one symptomatic tooth among those that are not included in this study&#xD;
&#xD;
          -  Known hypersensitivity to steroids, local anesthetics, or any component of study&#xD;
             medical devices;&#xD;
&#xD;
          -  Subject using long term anti-inflammatory drugs;&#xD;
&#xD;
          -  Use of illicit substances during the 48h before the first visit (cannabis, cocaine…);&#xD;
&#xD;
          -  Presence of any significant medical finding or significant history such as&#xD;
             uncontrolled systemic diseases that may impact the safety, the interpretation of the&#xD;
             results and/or the participation of the subject in the study according to the opinion&#xD;
             of the investigator;&#xD;
&#xD;
          -  Subject who cannot be contacted in case of emergency (phone number);&#xD;
&#xD;
          -  Simultaneous participation in another clinical trial or subject still within the&#xD;
             exclusion period of a previous clinical trial;&#xD;
&#xD;
          -  Vulnerable subjects (art. L.1121-5 and L.1122-1-2, Code of Public Health, France; art.&#xD;
             66 of the Regulation (EU) 2017/745 on medical devices)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yves BOUCHER, PU-PH</last_name>
    <role>Study Director</role>
    <affiliation>APHP</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Charlotte CAMELI</last_name>
    <phone>(0)2 99 12 19 62</phone>
    <phone_ext>+33</phone_ext>
    <email>c.cameli@slbpharma.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yanoura NOMANE, PhD</last_name>
    <phone>(0)1 49 76 74 35</phone>
    <phone_ext>+33</phone_ext>
    <email>ynomane@septodont.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cabinet dentaire</name>
      <address>
        <city>Agon-Coutainville</city>
        <zip>50230</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>SAMUEL VILLETTE, DDS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cabinet dentaire</name>
      <address>
        <city>Betton</city>
        <zip>35830</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>KEVIN NICHOLS, DDS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cabinet dentaire</name>
      <address>
        <city>Chartres-de-Bretagne</city>
        <zip>35131</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>RAOUL CABANTOUS, DDS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cabinet Dentaire</name>
      <address>
        <city>Cherbourg</city>
        <zip>50100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>FABRICE FOSSATI, DDS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cabinet dentaire</name>
      <address>
        <city>Cherbourg</city>
        <zip>50110</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ARNAUD PANASSIE, DDS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cabinet dentaire</name>
      <address>
        <city>Dinan</city>
        <zip>35800</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>LIONEL FERTE, DDS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre de santé dentaire Chevaleret</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>FRANCK MOYAL, DDS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre dentaire Flandre</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>FRANCK MOYAL, DDS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cabinet dentaire</name>
      <address>
        <city>Pluguffan</city>
        <zip>29700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>STEPHANE CANO, DDS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cabinet dentaire</name>
      <address>
        <city>Quimper</city>
        <zip>29000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>PIERRE LE DEN, DDS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cabinet dentaire</name>
      <address>
        <city>Saint-Aubin-de-Médoc</city>
        <zip>33160</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CLARA RICO MAHE, DDS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cabinet dentaire</name>
      <address>
        <city>Équeurdreville-Hainneville</city>
        <zip>50120</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CHARLOTTE LANGEVIN, DDS</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>April 29, 2021</study_first_submitted>
  <study_first_submitted_qc>May 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 13, 2021</study_first_posted>
  <last_update_submitted>September 28, 2021</last_update_submitted>
  <last_update_submitted_qc>September 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Endodontics</keyword>
  <keyword>root canal sealer</keyword>
  <keyword>post-operative pain</keyword>
  <keyword>zinc oxide eugenol</keyword>
  <keyword>hydrocortisone</keyword>
  <keyword>corticoid</keyword>
  <keyword>root canal treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Formaldehyde</mesh_term>
    <mesh_term>Thymol</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Hydrocortisone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

